The Company is actively engaging with pharmaceutical, academic, and investor audiences to strengthen existing and novel partnerships Vancouver, British Columbia–(Newsfile Corp. – May 11, 2026) – Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or…

Revenues are consistent with budget expectations and ahead of Q2 2025 comparative revenues Vancouver, British Columbia–(Newsfile Corp. – April 13, 2026) – Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"),…

Vancouver, British Columbia–(Newsfile Corp. – March 23, 2026) – Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value…

The chemistry technology companies aim to develop a next-generation chemical reactor for automated labs Vancouver, British Columbia–(Newsfile Corp. – March 16, 2026) – Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is…

Vancouver, British Columbia–(Newsfile Corp. – March 12, 2026) – Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) (the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical…